234 related articles for article (PubMed ID: 7857921)
1. A divalent metal ion binding site in the kinase insert domain of the alpha-platelet-derived growth factor receptor regulates its association with SH2 domains.
Mahadevan D; Thanki N; Aroca P; McPhie P; Yu JC; Beeler J; Santos E; Wlodawer A; Heidaran MA
Biochemistry; 1995 Feb; 34(7):2095-106. PubMed ID: 7857921
[TBL] [Abstract][Full Text] [Related]
2. Comparison of calcium-dependent conformational changes in the N-terminal SH2 domains of p85 and GAP defines distinct properties for SH2 domains.
Mahadevan D; Thanki N; McPhie P; Beeler JF; Yu JC; Wlodawer A; Heidaran MA
Biochemistry; 1994 Jan; 33(3):746-54. PubMed ID: 8292602
[TBL] [Abstract][Full Text] [Related]
3. In vitro association of the phosphatidylinositol 3-kinase regulatory subunit (p85) with the human insulin receptor.
Ottinger EA; Hui TY; Man Z; Barany G; Bernlohr DA
Int J Pept Protein Res; 1995 Nov; 46(5):346-53. PubMed ID: 8567177
[TBL] [Abstract][Full Text] [Related]
4. Solution structure of the C-terminal SH2 domain of the p85 alpha regulatory subunit of phosphoinositide 3-kinase.
Siegal G; Davis B; Kristensen SM; Sankar A; Linacre J; Stein RC; Panayotou G; Waterfield MD; Driscoll PC
J Mol Biol; 1998 Feb; 276(2):461-78. PubMed ID: 9512716
[TBL] [Abstract][Full Text] [Related]
5. Two signaling molecules share a phosphotyrosine-containing binding site in the platelet-derived growth factor receptor.
Nishimura R; Li W; Kashishian A; Mondino A; Zhou M; Cooper J; Schlessinger J
Mol Cell Biol; 1993 Nov; 13(11):6889-96. PubMed ID: 7692233
[TBL] [Abstract][Full Text] [Related]
6. Measurement of the binding of tyrosyl phosphopeptides to SH2 domains: a reappraisal.
Ladbury JE; Lemmon MA; Zhou M; Green J; Botfield MC; Schlessinger J
Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3199-203. PubMed ID: 7536927
[TBL] [Abstract][Full Text] [Related]
7. Functional interactions between isolated SH2 domains and insulin/Ras signaling pathways of Xenopus oocytes: opposite effects of the carboxy- and amino-terminal SH2 domains of p85 PI 3-kinase.
Aroca P; Mahadevan D; Santos E
Oncogene; 1996 Nov; 13(9):1839-46. PubMed ID: 8934529
[TBL] [Abstract][Full Text] [Related]
8. Insulin-stimulated oocyte maturation requires insulin receptor substrate 1 and interaction with the SH2 domains of phosphatidylinositol 3-kinase.
Chuang LM; Myers MG; Backer JM; Shoelson SE; White MF; Birnbaum MJ; Kahn CR
Mol Cell Biol; 1993 Nov; 13(11):6653-60. PubMed ID: 8413261
[TBL] [Abstract][Full Text] [Related]
9. Interaction of the p85 subunit of PI 3-kinase and its N-terminal SH2 domain with a PDGF receptor phosphorylation site: structural features and analysis of conformational changes.
Panayotou G; Bax B; Gout I; Federwisch M; Wroblowski B; Dhand R; Fry MJ; Blundell TL; Wollmer A; Waterfield MD
EMBO J; 1992 Dec; 11(12):4261-72. PubMed ID: 1330535
[TBL] [Abstract][Full Text] [Related]
10. Structure of a specific peptide complex of the carboxy-terminal SH2 domain from the p85 alpha subunit of phosphatidylinositol 3-kinase.
Breeze AL; Kara BV; Barratt DG; Anderson M; Smith JC; Luke RW; Best JR; Cartlidge SA
EMBO J; 1996 Jul; 15(14):3579-89. PubMed ID: 8670861
[TBL] [Abstract][Full Text] [Related]
11. In vivo binding properties of SH2 domains from GTPase-activating protein and phosphatidylinositol 3-kinase.
Cooper JA; Kashishian A
Mol Cell Biol; 1993 Mar; 13(3):1737-45. PubMed ID: 8382774
[TBL] [Abstract][Full Text] [Related]
12. Molecular interactions of the Src homology 2 domain protein Shb with phosphotyrosine residues, tyrosine kinase receptors and Src homology 3 domain proteins.
Karlsson T; Songyang Z; Landgren E; Lavergne C; Di Fiore PP; Anafi M; Pawson T; Cantley LC; Claesson-Welsh L; Welsh M
Oncogene; 1995 Apr; 10(8):1475-83. PubMed ID: 7537362
[TBL] [Abstract][Full Text] [Related]
13. Formation of signal transfer complexes between stem cell and platelet-derived growth factor receptors and SH2 domain proteins in vitro.
Herbst R; Shearman MS; Jallal B; Schlessinger J; Ullrich A
Biochemistry; 1995 May; 34(17):5971-9. PubMed ID: 7537096
[TBL] [Abstract][Full Text] [Related]
14. Ca2+-dependent antifreeze proteins. Modulation of conformation and activity by divalent metal ions.
Ewart KV; Yang DS; Ananthanarayanan VS; Fletcher GL; Hew CL
J Biol Chem; 1996 Jul; 271(28):16627-32. PubMed ID: 8663288
[TBL] [Abstract][Full Text] [Related]
15. The C-terminal SH2 domain of p85 accounts for the high affinity and specificity of the binding of phosphatidylinositol 3-kinase to phosphorylated platelet-derived growth factor beta receptor.
Klippel A; Escobedo JA; Fantl WJ; Williams LT
Mol Cell Biol; 1992 Apr; 12(4):1451-9. PubMed ID: 1312663
[TBL] [Abstract][Full Text] [Related]
16. The smaller isoforms of ankyrin 3 bind to the p85 subunit of phosphatidylinositol 3'-kinase and enhance platelet-derived growth factor receptor down-regulation.
Ignatiuk A; Quickfall JP; Hawrysh AD; Chamberlain MD; Anderson DH
J Biol Chem; 2006 Mar; 281(9):5956-64. PubMed ID: 16377635
[TBL] [Abstract][Full Text] [Related]
17. Insulin receptor substrate 1 binds two novel splice variants of the regulatory subunit of phosphatidylinositol 3-kinase in muscle and brain.
Antonetti DA; Algenstaedt P; Kahn CR
Mol Cell Biol; 1996 May; 16(5):2195-203. PubMed ID: 8628286
[TBL] [Abstract][Full Text] [Related]
18. Thermodynamics of binding of calcium, magnesium, and zinc to the N-methyl-D-aspartate receptor ion channel peptidic inhibitors, conantokin-G and conantokin-T.
Prorok M; Castellino FJ
J Biol Chem; 1998 Jul; 273(31):19573-8. PubMed ID: 9677382
[TBL] [Abstract][Full Text] [Related]
19. Specific binding of Fyn and phosphatidylinositol 3-kinase to the B cell surface glycoprotein CD19 through their src homology 2 domains.
Chalupny NJ; Aruffo A; Esselstyn JM; Chan PY; Bajorath J; Blake J; Gilliland LK; Ledbetter JA; Tepper MA
Eur J Immunol; 1995 Oct; 25(10):2978-84. PubMed ID: 7589101
[TBL] [Abstract][Full Text] [Related]
20. Tyr721 regulates specific binding of the CSF-1 receptor kinase insert to PI 3'-kinase SH2 domains: a model for SH2-mediated receptor-target interactions.
Reedijk M; Liu X; van der Geer P; Letwin K; Waterfield MD; Hunter T; Pawson T
EMBO J; 1992 Apr; 11(4):1365-72. PubMed ID: 1314163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
